Internal Medicine, Pulmonary Disease · Newark, NJ
NPI
1508883752
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
201 Lyons Ave, C-1
Newark, NJ, 07112
Phone (973) 926-4430
Groups this clinician bills Medicare through
Medicare paid, 2024
$17K
232 services
Medicare patients, 2024
110
Average age 68
Drug cost, 2024
$8.7M
891 prescriptions
Company payments, 2025
$1,834
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christina Migliore was code 99214 (office e&m - established), 76 times for 48 patients. In total Christina Migliore billed 232 services in 19 codes, and Medicare paid $17K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-03-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 76 | 48 | $79.58 | $6,048 |
| 99213 Office E&M - Established | Facility | 41 | 35 | $51.72 | $2,120 |
| 99215 Office E&M - Established | Facility | 23 | 18 | $115.26 | $2,651 |
| 99213 Office E&M - Established | Office | 13 | 12 | $74.62 | $970 |
By year: 2022 $14K for 193 services; 2023 $18K for 246 services; 2024 $17K for 232 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christina Migliore prescribed most often to Medicare patients was Opsumit (Macitentan), with 247 prescriptions and refills. In total Christina Migliore wrote 891 Medicare prescriptions that cost $8.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Opsumit Macitentan | 247 | 247 | 30 | $3.1M |
| Tadalafil Generic | 111 | 117 | 16 | $61K |
| Uptravi Selexipag | 103 | 103 | 14 | $2.3M |
| Remodulin Treprostinil Sodium | 54 | 54 | Under 11 | $517K |
| Tyvaso Dpi Treprostinil | 51 | 51 | 11 | $1.2M |
| Adcirca Tadalafil | 41 | 49 | Under 11 | $194K |
| Ambrisentan Generic | 29 | 29 | Under 11 | $68K |
| Adempas Riociguat | 25 | 25 | Under 11 | $337K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 23 | 31 | Under 11 | $18K |
| Orenitram Er Treprostinil Diolamine | 22 | 22 | Under 11 | $349K |
| Pirfenidone Generic | 22 | 22 | Under 11 | $43K |
| Furosemide Generic | 16 | 33 | Under 11 | $119 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 15 | 21 | Under 11 | $2,210 |
| Letairis Ambrisentan | 15 | 17 | Under 11 | $199K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 13 | 13 | Under 11 | $258 |
Brand drugs: 614 claims; generic drugs: 277 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christina Migliore $1,834 ($1,834 in general payments such as food, travel and fees) from 16 companies. The largest payer was Astellas Pharma US Inc with $464.
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc 4503.T | 13 | $464 |
| GlaxoSmithKline, LLC. GSK | 16 | $252 |
| United Therapeutics Corporation UTHR | 12 | $196 |
| Actelion Pharmaceuticals US, Inc. JNJ | 10 | $156 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $141 |
| Insmed, Inc. INSM | 11 | $138 |
| Viatris Specialty LLC | 6 | $118 |
| Merck Sharp & Dohme LLC MRK | 6 | $107 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $83.13 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $60.07 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.